|
US2914446A
(en)
|
1958-06-26 |
1959-11-24 |
Upjohn Co |
Nitrite stabilized ascorbic acid-cyanocobalamin compositions
|
|
US4650484A
(en)
|
1983-02-03 |
1987-03-17 |
Alza Corporation |
Method for treating ischemic conditions
|
|
IE64726B1
(en)
|
1987-11-20 |
1995-08-23 |
Elan Corp Plc |
Pharmaceutical formulations for preventing drug tolerance
|
|
US5122384A
(en)
|
1989-05-05 |
1992-06-16 |
Kv Pharmaceutical Company |
Oral once-per-day organic nitrate formulation which does not induce tolerance
|
|
US5278192A
(en)
|
1992-07-02 |
1994-01-11 |
The Research Foundation Of State University Of New York |
Method of vasodilator therapy for treating a patient with a condition
|
|
US6709681B2
(en)
|
1995-02-17 |
2004-03-23 |
Aberdeen University |
Acidified nitrite as an antimicrobial agent
|
|
US20110196039A9
(en)
|
1994-10-05 |
2011-08-11 |
Kaesemeyer Wayne H |
Controlled release arginine formulations
|
|
US5648101A
(en)
*
|
1994-11-14 |
1997-07-15 |
Tawashi; Rashad |
Drug delivery of nitric oxide
|
|
US5770645A
(en)
|
1996-08-02 |
1998-06-23 |
Duke University Medical Center |
Polymers for delivering nitric oxide in vivo
|
|
US5994444A
(en)
|
1997-10-16 |
1999-11-30 |
Medtronic, Inc. |
Polymeric material that releases nitric oxide
|
|
US7371415B1
(en)
|
1998-04-03 |
2008-05-13 |
The Daily Wellness Company |
Method and composition for improving sexual fitness
|
|
US7015876B1
(en)
|
1998-06-03 |
2006-03-21 |
Lear Corporation |
Heads-up display with improved contrast
|
|
US6103275A
(en)
*
|
1998-06-10 |
2000-08-15 |
Nitric Oxide Solutions |
Systems and methods for topical treatment with nitric oxide
|
|
EP1105146A1
(en)
|
1998-07-14 |
2001-06-13 |
Paracelsian, Inc. |
Method for identifying and confirming consistent bio-functionality of natural compositions
|
|
AU764469B2
(en)
|
1999-01-29 |
2003-08-21 |
Disphar International B.V. |
Pharmaceutical compositions
|
|
GB9905425D0
(en)
|
1999-03-09 |
1999-05-05 |
Queen Mary & Westfield College |
Pharmaceutical composition
|
|
US6314956B1
(en)
|
1999-09-08 |
2001-11-13 |
Duke University |
Pulmonary delivery of NO group-containing compound in gas form to treat respiratory, cardiac and blood disorders
|
|
DE60125191T2
(de)
*
|
2000-07-28 |
2007-10-25 |
Bioenergy Inc., Ham Lake |
Zusammensetzungen und methoden zur verbesserung der kardiovaskulären funktion
|
|
GB0119011D0
(en)
|
2001-08-03 |
2001-09-26 |
Univ Aberdeen |
Treatment of nail infections
|
|
EP1492509A1
(en)
|
2001-12-18 |
2005-01-05 |
ALZA Corporation |
Dosage form providing time-varying patterns of drug delivery
|
|
EP1336602A1
(en)
|
2002-02-13 |
2003-08-20 |
Giovanni Scaramuzzino |
Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases
|
|
CA2379211A1
(fr)
|
2002-03-28 |
2003-09-28 |
Institut De Cardiologie De Montreal |
Utilisation du bleu de methylene pour renverser la reaction hemodynamique exageree induite par la combinaison d'un derive nitre et du sildenafil ou d'une molecule de meme classe (inhibiteur de la phosphodiesterase)
|
|
JP5564157B2
(ja)
|
2003-07-09 |
2014-07-30 |
ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ アズ リプレゼンテッド バイ ザ セクレタリー オブ ザ デパートメント オブ ヘルス アンド ヒューマン サービシーズ |
心臓血管状態の処置のための亜硝酸塩の使用方法
|
|
EP1670459A4
(en)
|
2003-08-20 |
2009-03-25 |
Nitromed Inc |
NITROSED AND NITROSYLATED CARDIOVASCULAR COMPOUNDS, COMPOSITIONS AND APPLICATION METHODS
|
|
WO2005023189A2
(en)
*
|
2003-09-03 |
2005-03-17 |
Pharmacia Corporation |
Method of cox-2 selective inhibitor and nitric oxide-donating agent
|
|
US7362274B1
(en)
*
|
2004-07-09 |
2008-04-22 |
Huan-Cheng Lien |
Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna
|
|
US20060083824A1
(en)
|
2004-10-20 |
2006-04-20 |
Pbm Products Llc |
Nutritional supplements for glucose intolerant individuals
|
|
BRPI0610180A2
(pt)
|
2005-05-24 |
2012-09-25 |
Wellgen Inc |
métodos para prevenir, para tratar, e para tratar ou controlar uma condição associada à inflamação
|
|
NZ594596A
(en)
|
2006-02-10 |
2011-10-28 |
Mannatech Inc |
All natural multivitamin and multimineral dietary supplement formulations for enhanced absorption and biological utilization
|
|
GB0607402D0
(en)
|
2006-04-12 |
2006-05-24 |
Barts & London Nhs Trust |
Therapeutic composition and use
|
|
WO2007149520A2
(en)
*
|
2006-06-21 |
2007-12-27 |
Albert Einstein College Of Medicine Of Yeshiva University |
Compositions for sustained release of nitric oxide, methods of preparing same and uses thereof
|
|
JP2010519336A
(ja)
*
|
2007-02-26 |
2010-06-03 |
ルンドベルク，ヨン |
亜硝酸塩及び硝酸塩及びこれらを含む組成物の新規使用
|
|
PL2124638T3
(pl)
|
2007-02-26 |
2017-07-31 |
Heartbeet Ltd. |
Kompozycja zwiększająca wydolność i jej zastosowanie
|
|
WO2008153762A2
(en)
|
2007-05-25 |
2008-12-18 |
N30 Pharmaceuticals, Llc |
S-nitrosothiol formulations and storage systems
|
|
CN101939014B
(zh)
|
2007-11-15 |
2016-04-27 |
路易斯安那州大学及农业和机械学院管理委员会 |
亚硝酸盐在慢性缺血中的应用
|
|
US20090196930A1
(en)
|
2007-12-27 |
2009-08-06 |
Aires Pharmaceuticals, Inc. |
Aerosolized nitrite and nitric oxide -donating compounds and uses thereof
|
|
WO2010036236A1
(en)
|
2008-09-23 |
2010-04-01 |
Baker Hughes Incorporated |
Anchor assembly
|
|
US8568793B2
(en)
|
2009-02-11 |
2013-10-29 |
Hope Medical Enterprises, Inc. |
Sodium nitrite-containing pharmaceutical compositions
|
|
WO2010147742A2
(en)
|
2009-06-18 |
2010-12-23 |
Theravasc Inc. |
Use of nitrite salts in treating tissue damage
|
|
CA2777066C
(en)
|
2009-10-14 |
2020-02-18 |
TheraVasc, LLC |
Pharmaceutical formulations of nitrite and uses thereof
|
|
US20130209584A1
(en)
|
2009-10-14 |
2013-08-15 |
Theravasc Inc. |
Pharmaceutical formulations of nitrite and uses thereof
|
|
WO2012135623A1
(en)
|
2011-03-31 |
2012-10-04 |
Theravasc Inc. |
Use of nitrites for the treatment of cerebral amyloid angiopathy, age associated dementia, and cognitive decline
|
|
WO2012142413A2
(en)
|
2011-04-14 |
2012-10-18 |
Theravasc Inc. |
Nitrite compositions and uses thereof
|
|
US9294956B2
(en)
|
2011-12-29 |
2016-03-22 |
Qualcomm Incorporated |
Application-server-assisted preemptive multicast bearer establishment for real-time low-latency applications
|
|
ES2741146T3
(es)
*
|
2013-02-20 |
2020-02-10 |
The Board Of Supervisors Of The Louisiana State Univ Mechanical And Agricultural College |
Formulaciones farmacéuticas de nitrio y sus usos
|